Keros Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.5M | 63k | 39.76 |
| 2023-09-30 | $1.7M | 53k | 31.88 |
| 2023-06-30 | $1.2M | 30k | 40.18 |
| 2023-03-31 | $1000k | 23k | 42.70 |
| 2022-12-31 | $2.0M | 42k | 47.97 |
| 2022-06-30 | $421k | 15k | 27.63 |
| 2022-03-31 | $2.0M | 38k | 54.37 |
| 2021-12-31 | $1.9M | 33k | 58.41 |
| 2021-03-31 | $393k | 6.4k | 61.48 |
| 2020-12-31 | $411k | 5.8k | 70.49 |
| 2020-09-30 | $102k | 2.6k | 39.28 |
| 2020-06-30 | $88k | 2.3k | 37.56 |